COMMUNIQUÉS West-GlobeNewswire

23andMe Initiates Voluntary Chapter 11 Process to Maximize Stakeholder Value Through Court-Supervised Sale Process
24/03/2025
Intends to use Proceedings to Conduct a Value-Maximizing Sale Process and Resolve Liabilities Company Expects to Continue Business Operations in the Ordinary Course During Proceedings; Secures Commitment for [...]
UNITY Biotechnology to Host Virtual Investor Event to Discuss 24- and 36-Week Data from the Phase 2b ASPIRE Study of UBX1325 in Patients with Diabetic Macular Edema (DME) on March 24, 2025
23/03/2025
SOUTH SAN FRANCISCO, Calif., March 23, 2025 (GLOBE NEWSWIRE) -- UNITY Biotechnology, Inc. (“UNITY”) [NASDAQ: UBX], a biotechnology company developing therapeutics to slow, halt, or reverse diseases of aging, today [...]
Ever Joint Benefits: How This Supplement Supports Flexibility and Weight Loss
22/03/2025
TALLMADGE, Ohio, March 22, 2025 (GLOBE NEWSWIRE) -- Weight management remains a paramount concern for many individuals in the ever-evolving health and wellness world. In pursuit of practical solutions, countless [...]
Best Steroids For Bodybuilding (Muscle Growth & Bulking) From CrazyBulk in 2025
22/03/2025
NEW YORK, March 22, 2025 (GLOBE NEWSWIRE) -- “ CrazyBulk Stacks. Want the best results? Then you gotta stack it. Each stack features our very best bodybuilding supplements which work synergistically together to give you [...]
Financière de Tubize - Annual report 2024
22/03/2025
Annual Report 2024 Regulated information 22 March 2025 The board of directors of Financière de Tubize has established the 2024 annual report. This report is available on the website www.financiere-tubize.be Profit for [...]
Financière de Tubize - Rapport annuel
22/03/2025
Rapport annuel 2024 Informations réglementées - 22 mars 2025 Le conseil d’administration de la Financière de Tubize a établi le rapport annuel 2024. Ce rapport est disponible sur le site internet www.financiere-tubize. [...]
Prime Biome Reviews 2025 (Investigative Report) Ingredients, Benefits, Complaints, And Honest Consumer Report!
22/03/2025
ST. PETERSBURG, Fla., March 22, 2025 (GLOBE NEWSWIRE) -- Prime Biome is a probiotic for skin and digestion that helps rejuvenate the skin by replacing old cells with new ones. The supplement is said to maintain the skin [...]
Arialief Reviews (Is It Safe And Legit To Use?) What Do Arialief Consumer Reports Say About Its Efficacy?
22/03/2025
AURORA, Colo., March 22, 2025 (GLOBE NEWSWIRE) -- Arialief is a unique nerve pain and discomfort relief supplement with natural herbs and powerful ingredients. The unique composition of the formula makes it stand out [...]
ProDentim Reviews (2025) Is This Probiotic Formula Really A Game-Changer For Teeth And Gum Health?
22/03/2025
TALLMADGE, Ohio, March 22, 2025 (GLOBE NEWSWIRE) -- qProDentim is designed to improve oral health naturally. It contains carefully chosen ingredients to balance the oral microbiome. It fights against harmful bacteria to [...]
Genmab to Vigorously Defend Alleged Claims of Trade Secret Misappropriation by AbbVie Inc.
22/03/2025
Company Announcement AbbVie Inc. files complaint against Genmab in the U.S. District Court for the Western District of Washington (Seattle) Genmab categorically refutes allegations and will vigorously defend the company [...]
Atea Pharmaceuticals Issues Statement Regarding Director Nominations
21/03/2025
No Shareholder Action is Required at this Time BOSTON, March 21, 2025 (GLOBE NEWSWIRE) -- Atea Pharmaceuticals, Inc. (Nasdaq: AVIR) (Atea or Company) a clinical-stage biopharmaceutical company engaged in the discovery [...]
Iovance Biotherapeutics Reports Inducement Grants under NASDAQ Listing Rule 5635(c)(4)
21/03/2025
SAN CARLOS, Calif., March 21, 2025 (GLOBE NEWSWIRE) -- Iovance Biotherapeutics, Inc. (NASDAQ: IOVA) ("Iovance" or the “Company”), a biotechnology company focused on innovating, developing, and delivering novel [...]
Annovis Provides Corporate Updates and Reports Fourth Quarter and Fiscal Year 2024 Financial Results
21/03/2025
MALVERN, Pa., March 21, 2025 (GLOBE NEWSWIRE) -- Annovis Bio Inc. (NYSE: ANVS) ("Annovis" or the “Company”), a late-stage clinical drug platform company pioneering transformative therapies for neurodegenerative diseases [...]
Restore Value Slate Led by Mina Sooch Files Preliminary Proxy Materials for the Election of Six Highly Qualified Directors at the 2025 Annual Meeting of Opus Genetics
21/03/2025
Believes that Current Board’s Strategic, Management and Capital Allocation Failures have Resulted in Stockholder Value Destruction Highlights Serious Concerns with the Opus Merger and the Company’s Underperformance [...]
Autonomix Medical, Inc. Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
21/03/2025
THE WOODLANDS, TX, March 21, 2025 (GLOBE NEWSWIRE) -- Autonomix Medical, Inc. (NASDAQ: AMIX) (“Autonomix” or the “Company”), a medical device company focused on advancing innovative technologies to revolutionize how [...]
Immuneering Corporation Announces Grant of Inducement Award
21/03/2025
CAMBRIDGE, Mass., March 21, 2025 (GLOBE NEWSWIRE) -- Immuneering Corporation (Nasdaq: IMRX), a clinical-stage oncology company seeking to develop and commercialize more effective and better tolerated therapies for [...]
Baylor Genetics Presents New Data on Genetic and Functional Testing to Diagnose Mitochondrial Disorders at 2025 ACMG Annual Clinical Genetics Meeting
21/03/2025
Research underscores importance of both genetic and functional testing in diagnosing mitochondrial disorders, particularly for cases with low-heteroplasmy deletions that otherwise could go undetected HOUSTON, March 21, [...]
I-Mab Announces Receipt Of Nasdaq Deficiency Notice Regarding Minimum Bid Price Requirement
21/03/2025
ROCKVILLE, Md., March 21, 2025 (GLOBE NEWSWIRE) -- I-Mab (NASDAQ: IMAB) (“I-Mab” or the “Company”), announced today that on March 19, 2025 it received a written notice (the “Notice”) from the Listing Qualifications [...]
Eagle Pharmaceuticals Announces Amendment to Limited Duration Stockholder Rights Plan
21/03/2025
WOODCLIFF LAKE, N.J., March 21, 2025 (GLOBE NEWSWIRE) -- Eagle Pharmaceuticals, Inc. (OTCMKTS: EGRX) (the “Company” or “Eagle”) today announced that its Board of Directors (the “Board”) has approved an amendment to its [...]

Pages